176 related articles for article (PubMed ID: 31228452)
1. New insight into systemic mastocytosis mediated by cytokines IL-1β and IL-33: Potential inhibitory effect of IL-37.
Conti P; Lauritano D; Caraffa A; Gallenga CE; Kritas SK; Ronconi G; Pandolfi F
Eur J Pharmacol; 2019 Sep; 858():172473. PubMed ID: 31228452
[TBL] [Abstract][Full Text] [Related]
2. Transglutaminase 2 expressed in mast cells recruited into skin or bone marrow induces the development of pediatric mastocytosis.
Ahn YM; Hong GU; Kim SH; Lee HJ; Baek HS; Kim MN; Park KY; Ro JY
Pediatr Allergy Immunol; 2015 Aug; 26(5):438-45. PubMed ID: 25952500
[TBL] [Abstract][Full Text] [Related]
3. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE; Tetlow LC
Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
[TBL] [Abstract][Full Text] [Related]
4. Impact of mast cells in depression disorder: inhibitory effect of IL-37 (new frontiers).
Conti P; Caraffa A; Ronconi G; Conti CM; Kritas SK; Mastrangelo F; Tettamanti L; Theoharides TC
Immunol Res; 2018 Jun; 66(3):323-331. PubMed ID: 29907890
[TBL] [Abstract][Full Text] [Related]
5. Mast Cell Cytokines in Acute and Chronic Gingival Tissue Inflammation: Role of IL-33 and IL-37.
Trimarchi M; Lauritano D; Ronconi G; Caraffa A; Gallenga CE; Frydas I; Kritas SK; Calvisi V; Conti P
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362030
[TBL] [Abstract][Full Text] [Related]
6. Stimulated mast cells release inflammatory cytokines: potential suppression and therapeutical aspects.
Varvara G; Tettamanti L; Gallenga CE; Caraffa Al; D'Ovidio C; Mastrangelo F; Ronconi G; Kritas SK; Conti P
J Biol Regul Homeost Agents; 2018; 32(6):1355-1360. PubMed ID: 30574739
[TBL] [Abstract][Full Text] [Related]
7. Microglia and mast cells generate proinflammatory cytokines in the brain and worsen inflammatory state: Suppressor effect of IL-37.
Conti P; Lauritano D; Caraffa A; Gallenga CE; Kritas SK; Ronconi G; Martinotti S
Eur J Pharmacol; 2020 May; 875():173035. PubMed ID: 32097657
[TBL] [Abstract][Full Text] [Related]
8. Protease profile of normal and neoplastic mast cells in the human bone marrow with special emphasis on systemic mastocytosis.
Atiakshin D; Buchwalow I; Horny P; Tiemann M
Histochem Cell Biol; 2021 May; 155(5):561-580. PubMed ID: 33492488
[TBL] [Abstract][Full Text] [Related]
9. IL-33 mediates allergy through mast cell activation: Potential inhibitory effect of certain cytokines.
Tettamanti L; Kritas SK; Gallenga CE; D'Ovidio C; Mastrangelo F; Ronconi G; Caraffa Al; Toniato E; Conti P
J Biol Regul Homeost Agents; 2018; 32(5):1061-1065. PubMed ID: 30334399
[TBL] [Abstract][Full Text] [Related]
10. Impact of TNF and IL-33 Cytokines on Mast Cells in Neuroinflammation.
Conti P; Ronconi G; Lauritano D; Mastrangelo F; Caraffa A; Gallenga CE; Frydas I; Kritas SK; Carinci F; Gaudelli F; Annicchiarico C; D'Ovidio C
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542222
[TBL] [Abstract][Full Text] [Related]
11. Mast Cell Cytokines IL-1, IL-33, and IL-36 Mediate Skin Inflammation in Psoriasis: A Novel Therapeutic Approach with the Anti-Inflammatory Cytokines IL-37, IL-38, and IL-1Ra.
Conti P; Pregliasco FE; Bellomo RG; Gallenga CE; Caraffa A; Kritas SK; Lauritano D; Ronconi G
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360845
[TBL] [Abstract][Full Text] [Related]
12. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
13. Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts.
Valent P; Akin C; Hartmann K; Nilsson G; Reiter A; Hermine O; Sotlar K; Sperr WR; Escribano L; George TI; Kluin-Nelemans HC; Ustun C; Triggiani M; Brockow K; Gotlib J; Orfao A; Kovanen PT; Hadzijusufovic E; Sadovnik I; Horny HP; Arock M; Schwartz LB; Austen KF; Metcalfe DD; Galli SJ
Theranostics; 2020; 10(23):10743-10768. PubMed ID: 32929378
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 family cytokines and mast cells: activation and inhibition.
Gallenga CE; Pandolfi F; Caraffa Al; Kritas SK; Ronconi G; Toniato E; Martinotti S; Conti P
J Biol Regul Homeost Agents; 2019 Jan-Feb,; 33(1):1-6. PubMed ID: 30656901
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 33 and interleukin 4 regulate interleukin 31 gene expression and secretion from human laboratory of allergic diseases 2 mast cells stimulated by substance P and/or immunoglobulin E.
Petra AI; Tsilioni I; Taracanova A; Katsarou-Katsari A; Theoharides TC
Allergy Asthma Proc; 2018 Mar; 39(2):153-160. PubMed ID: 29490771
[TBL] [Abstract][Full Text] [Related]
16. IL-33 and IgE stimulate mast cell production of IL-2 and regulatory T cell expansion in allergic dermatitis.
Salamon P; Shefler I; Moshkovits I; Munitz A; Horwitz Klotzman D; Mekori YA; Hershko AY
Clin Exp Allergy; 2017 Nov; 47(11):1409-1416. PubMed ID: 28892206
[TBL] [Abstract][Full Text] [Related]
17. Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells.
Conti P; Carinci F; Lessiani G; Spinas E; Kritas SK; Ronconi G; Caraffa A; Theoharides TC
Immunol Res; 2017 Oct; 65(5):982-986. PubMed ID: 28748328
[TBL] [Abstract][Full Text] [Related]
18. Mast cells and mastocytosis.
Söderholm JD
Dig Dis; 2009; 27 Suppl 1():129-36. PubMed ID: 20203509
[TBL] [Abstract][Full Text] [Related]
19. Single-cell analysis reveals the KIT D816V mutation in haematopoietic stem and progenitor cells in systemic mastocytosis.
Grootens J; Ungerstedt JS; Ekoff M; Rönnberg E; Klimkowska M; Amini RM; Arock M; Söderlund S; Mattsson M; Nilsson G; Dahlin JS
EBioMedicine; 2019 May; 43():150-158. PubMed ID: 30975542
[TBL] [Abstract][Full Text] [Related]
20. Mast cells emerge as mediators of atherosclerosis: Special emphasis on IL-37 inhibition.
Conti P; Lessiani G; Kritas SK; Ronconi G; Caraffa A; Theoharides TC
Tissue Cell; 2017 Jun; 49(3):393-400. PubMed ID: 28420489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
